SouthState Corp Has $18.32 Million Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

SouthState Corp boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.3% during the third quarter, Holdings Channel.com reports. The institutional investor owned 37,280 shares of the medical equipment provider’s stock after acquiring an additional 488 shares during the quarter. Intuitive Surgical accounts for approximately 1.3% of SouthState Corp’s portfolio, making the stock its 24th largest position. SouthState Corp’s holdings in Intuitive Surgical were worth $18,315,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Ridgewood Investments LLC acquired a new position in Intuitive Surgical during the second quarter worth approximately $26,000. Godsey & Gibb Inc. grew its position in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the last quarter. Creekmur Asset Management LLC grew its position in shares of Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 42 shares during the last quarter. LGT Financial Advisors LLC grew its position in shares of Intuitive Surgical by 415.4% in the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 54 shares during the last quarter. Finally, MidAtlantic Capital Management Inc. acquired a new position in shares of Intuitive Surgical in the third quarter valued at approximately $33,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 0.8 %

NASDAQ ISRG opened at $531.64 on Tuesday. The company has a market capitalization of $189.36 billion, a price-to-earnings ratio of 85.47, a PEG ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a twelve month low of $304.50 and a twelve month high of $544.38. The stock has a fifty day simple moving average of $500.33 and a 200 day simple moving average of $459.58.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The business had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. Research analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several research reports. Royal Bank of Canada upped their target price on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. Truist Financial upped their target price on Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a research report on Monday, October 14th. Leerink Partners upped their target price on Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Mizuho boosted their price target on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Finally, Raymond James boosted their price target on Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research note on Monday, October 14th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average price target of $524.61.

Insider Activity at Intuitive Surgical

In related news, SVP Henry L. Charlton sold 40,243 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the sale, the senior vice president now directly owns 3,001 shares in the company, valued at $1,461,006.84. This represents a 93.06 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Mark Brosius sold 2,128 shares of the stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,095,920.00. Following the completion of the sale, the senior vice president now owns 273 shares of the company’s stock, valued at $140,595. The trade was a 88.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 91,178 shares of company stock worth $45,897,071 over the last three months. Company insiders own 0.80% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.